Suvanza Net Tangible Assets from 2010 to 2026
| SUVZ Stock | USD 0.0002 0.00 0.00% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter 691.2 K | Current Value 656.6 K | Quarterly Volatility 2.1 M |
Check Suvanza Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Suvanza Pharma's main balance sheet or income statement drivers, such as Discontinued Operations of 539.2 K, Interest Expense of 0.0 or Selling General Administrative of 9.9 M, as well as many indicators such as . Suvanza financial statements analysis is a perfect complement when working with Suvanza Pharma Valuation or Volatility modules.
Suvanza | Net Tangible Assets | Build AI portfolio with Suvanza Stock |
Latest Suvanza Pharma's Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Suvanza Pharma LLC over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Suvanza Pharma's Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Suvanza Pharma's overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Suvanza Net Tangible Assets Regression Statistics
| Arithmetic Mean | 1,265,814 | |
| Geometric Mean | 876,406 | |
| Coefficient Of Variation | 166.00 | |
| Mean Deviation | 959,198 | |
| Median | 768,000 | |
| Standard Deviation | 2,101,267 | |
| Sample Variance | 4.4T | |
| Range | 8.8M | |
| R-Value | (0.42) | |
| Mean Square Error | 3.9T | |
| R-Squared | 0.17 | |
| Significance | 0.1 | |
| Slope | (173,129) | |
| Total Sum of Squares | 70.6T |
Suvanza Net Tangible Assets History
About Suvanza Pharma Financial Statements
Suvanza Pharma investors use historical fundamental indicators, such as Suvanza Pharma's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Suvanza Pharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | 691.2 K | 656.6 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Suvanza Stock Analysis
When running Suvanza Pharma's price analysis, check to measure Suvanza Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Suvanza Pharma is operating at the current time. Most of Suvanza Pharma's value examination focuses on studying past and present price action to predict the probability of Suvanza Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Suvanza Pharma's price. Additionally, you may evaluate how the addition of Suvanza Pharma to your portfolios can decrease your overall portfolio volatility.